Flow-synchronized nasal intermittent positive pressure ventilation for infants C Gizzi  1 , P Papoff, I Giordano, L Massenzi, C S Barbàra, M Campelli, V Panetta, R Agostino, C Moretti Affiliations Expand Affiliation 1 Neonatal Intensive Care Unit, Pediatric and Neonatal Department, "S.Giovanni Calibita" Fatebenefratelli Hospital, Isola Tiberina, Via Ponte Quattro Capi, 39-00186 Rome, Italy. PMID: 23227317 PMCID: PMC3514808 DOI: 10.1155/2012/301818 Free PMC article Item in Clipboard

C Gizzi, P Papoff, I Giordano, L Massenzi, C S Barbàra, M Campelli, V Panetta, R Agostino, C Moretti, C Gizzi, P Papoff, I Giordano, L Massenzi, C S Barbàra, M Campelli, V Panetta, R Agostino, C Moretti

Abstract

Aim. To evaluate whether synchronized-NIPPV (SNIPPV) used after the INSURE procedure can reduce mechanical ventilation (MV) need in preterm infants with RDS more effectively than NCPAP and to compare the clinical course and the incidence of short-term outcomes of infants managed with SNIPPV or NCPAP. Methods. Chart data of inborn infants <32 weeks undergoing INSURE approach in the period January 2009-December 2010 were reviewed. After INSURE, newborns born January -December 2009 received NCPAP, whereas those born January-December 2010 received SNIPPV. INSURE failure was defined as FiO(2) need >0.4, respiratory acidosis, or intractable apnoea that occurred within 72 hours of surfactant administration. Results. Eleven out of 31 (35.5%) infants in the NCPAP group and 2 out of 33 (6.1%) infants in the SNIPPV group failed the INSURE approach and underwent MV (P < 0.004). Fewer infants in the INSURE/SNIPPV group needed a second dose of surfactant, a high caffeine maintenance dose, and pharmacological treatment for PDA. Differences in O(2) dependency at 28 days and 36 weeks of postmenstrual age were at the limit of significance in favor of SNIPPV treated infants. Conclusions. SNIPPV use after INSURE technique in our NICU reduced MV need and favorably affected short-term morbidities of our premature infants.

References

    1. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB. Nasal CPAP or intubation at birth for very preterm infants. The New England Journal of Medicine. 2008;358(7):700–708.
    1. Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. The New England Journal of Medicine. 2010;362(21):1970–1979.
    1. Dunn MS, Kaempf J, de Klerk A, et al. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics. 2011;128(5):e1069–e1076.
    1. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. The New England Journal of Medicine. 1994;331(16):1051–1055.
    1. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks’ gestation. Pediatrics. 1999;103(2, article E24)
    1. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants < 30 weeks’ gestation. Pediatrics. 2004;113(6):e560–563.
    1. Reininger A, Khalak R, Kendig JW, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks’ gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. Journal of Perinatology. 2005;25(11):703–708.
    1. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. Journal of Perinatology. 2007;27(7):422–427.
    1. Rojas MA, Lozano JM, Rojas MX, et al. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics. 2009;123(1):137–142.
    1. DiBlasi RM. Neonatal noninvasive ventilation techniques: do we really need to intubate? Respiratory Care. 2011;56(9):1273–1294.
    1. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation versus selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews. 2007;(4)CD003063
    1. Kiciman NM, Andréasson B, Bernstein G, et al. Thoracoabdominal motion in newborns during ventilation delivered by endotracheal tube or nasal prongs. Pediatric Pulmonology. 1998;25(3):175–181.
    1. Owen LS, Morley CJ, Dawson JA, Davis PG. Effects of non-synchronised nasal intermittent positive pressure ventilation on spontaneous breathing in preterm infants. Archives of Disease in Childhood: Fetal and Neonatal Edition. 2011;96(6):F422–F428.
    1. Moretti C, Gizzi C, Papoff P, et al. Comparing the effects of nasal synchronized intermittent positive pressure ventilation (nSIPPV) and nasal continuous positive airway pressure (nCPAP) after extubation in very low birth weight infants. Early Human Development. 1999;56(2-3):167–177.
    1. Aghai ZH, Saslow JG, Nakhla T, et al. Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to nasal continuous positive airway pressure (NCPAP) Pediatric Pulmonology. 2006;41(9):875–881.
    1. Chang HY, Claure N, D’Ugard C, Torres J, Nwajei P, Bancalari E. Effects of synchronization during nasal ventilation in clinically stable preterm infants. Pediatric Research. 2011;69(1):84–89.
    1. Greenough A, Dimitriou G, Prendergast M, Milner AD. Synchronized mechanical ventilation for respiratory support in newborn infants. Cochrane Database of Systematic Reviews. 2008;(1)CD000456
    1. Moretti C, Giannini L, Fassi C, Gizzi C, Papoff P, Colarizi P. Nasal flow-synchronized intermittent positive pressure ventilation to facilitate weaning in very low-birthweight infants: unmasked randomized controlled trial. Pediatrics International. 2008;50(1):85–91.
    1. Volpe JJ. Neurology of the Newborn. 3rd edition. Philadelphia, Pa, USA: WB Saunders; 1995.
    1. de Vries LS, Eken P, Dubowitz LMS. The spectrum of leukomalacia using cranial ultrasound. Behavioural Brain Research. 1992;49(1):1–6.
    1. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery. 1978;187(1):1–7.
    1. International Committee for Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Archives of Ophthalmology. 2005;123(7):991–999.
    1. The International Neonatal Network. The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. The Lancet. 1993;342(8865):193–198.
    1. de Courcy-Wheeler RHB, Wolfe CDA, Fitzgerald A, Spencer M, Goodman JDS, Gamsu HR. Use of the CRIB (clinical risk index for babies) score in prediction of neonatal mortality and morbidity. Archives of Disease in Childhood. 1995;73(1):F32–F36.
    1. Kero PO, Mäkinen EO. Comparison between clinical and radiological classifications of infants with the respiratory distress syndrome (RDS) European Journal of Pediatrics. 1979;130(4):271–278.
    1. Bisceglia M, Belcastro A, Poerio V, et al. A comparison of nasal intermittent versus continuous positive pressure delivery for the treatment of moderate respiratory syndrome in preterm infants. Minerva Pediatrica. 2007;59(2):91–95.
    1. Barrington KJ, Bull D, Finer NN. Randomized trial of nasal synchronized intermittent mandatory ventilation compared with continuous positive airway pressure after extubation of very low birth weight infants. Pediatrics. 2001;107(4):638–641.
    1. Lin CH, Wang ST, Lin YJ, Yeh TF. Efficacy of nasal intermittent positive pressure ventilation in treating apnea of prematurity. Pediatric Pulmonology. 1998;26(5):349–353.
    1. Ryan CA, Finer NN, Peters KL. Nasal intermittent positive-pressure ventilation offers no advantages over nasal continuous positive airway pressure in apnea of prematurity. American Journal of Diseases of Children. 1989;143(10):1196–1198.
    1. Pantalitschka T, Sievers J, Urschitz MS, Herberts T, Reher C, Poets CF. Randomised crossover trial of four nasal respiratory support systems for apnoea of prematurity in very low birthweight infants. Archives of Disease in Childhood: Fetal and Neonatal Edition. 2009;94(4):F245–F248.
    1. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. Journal of Pediatrics. 2007;150(5):521.e1–526.e1.
    1. Sai Sunil Kishore M, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatrica. 2009;98(9):1412–1415.
    1. Meneses J, Bhandari V, Alves JG, Herrmann D. Noninvasive ventilation for respiratory distress syndrome: a randomized controlled trial. Pediatrics. 2011;127(2):300–307.
    1. Kulkarni A, Ehrenkranz RA, Bhandari V. Effect of introduction of synchronized nasal intermittent positive-pressure ventilation in a neonatal intensive care unit on bronchopulmonary dysplasia and growth in preterm infants. American Journal of Perinatology. 2006;23(4):233–240.
    1. Bhandari V, Gavino RG, Nedrelow JH, et al. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. Journal of Perinatology. 2007;27(11):697–703.
    1. Bhandari V, Finer NN, Ehrenkranz RA, et al. Synchronized nasal intermittent positive-pressure ventilation and neonatal outcomes. Pediatrics. 2009;124(2):517–526.
    1. Ramanathan R, Sekar KC, Rasmussen M, Bhatia J, Soll RF. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants < 30 weeks' gestation: a randomized, controlled trial. Journal of Perinatology. 2012;32(5):336–343.
    1. Avery ME, Tooley WH, Keller JB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987;79(1):26–30.
    1. van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics. 2000;105(6):1194–1201.
    1. Cherif A, Hachani C, Khrouf N. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants. American Journal of Perinatology. 2008;25(10):647–652.
    1. Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, van Hoestenberghe MR, Theyskens C. Conservative treatment for patent ductus arteriosus in the preterm. Archives of Disease in Childhood: Fetal and Neonatal Edition. 2007;92(4):F244–F247.
    1. Dani C, Corsini I, Poggi C. Risk factors for intubation-surfactant-extubation (INSURE) failure and multiple INSURE strategy in preterm infants. Early Human Development. 2012;88(supplement 1):S3–S4.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit